- Home
- NMI vs CBUS Comparison
NMI vs CBUS Comparison
Compare NMI & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NMI | CBUS |
|---|---|---|
| Founded | N/A | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Agricultural Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.5M | 116.2M |
| IPO Year | 1995 | 2017 |
Fundamental Metrics
Financial Performance| Metric | NMI | CBUS |
|---|---|---|
| Price | $9.70 | $1.25 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $14.33 |
| AVG Volume (30 Days) | ★ 68.9K | 63.9K |
| Earning Date | 01-01-0001 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 74.33 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,639,000.00 |
| Revenue This Year | N/A | $42.75 |
| Revenue Next Year | N/A | $139.28 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.10 | $1.09 |
| 52 Week High | $11.28 | $4.19 |
Technical Indicators
Market Signals| Indicator | NMI | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 62.26 | 37.78 |
| Support Level | $9.57 | N/A |
| Resistance Level | $10.97 | $1.62 |
| Average True Range (ATR) | 0.18 | 0.13 |
| MACD | 0.06 | -0.01 |
| Stochastic Oscillator | 98.33 | 25.68 |
Price Performance
Historical ComparisonAbout NMI Nuveen Municipal Income Fund Inc.
Nuveen Municipal Income Fund Inc is a diversified, closed-end management investment company. The Fund's investment objective is to provide a high level of current income exempt from federal income tax, which it seeks to achieve by investing mainly in a diversified portfolio of tax-exempt municipal obligations.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.